Publications

LSHTM

Found 0 results for your search. Showing 0 to 0.

No results could be found for your search.

A non-exhaustive repository of COVID-19 related scientific publications undertaken by LSHTM researchers since the beginning of the outbreak.

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.

DAVIES, NG; ABBOTT, S; BARNARD, RC; JARVIS, CI; KUCHARSKI, AJ; MUNDAY, JD; PEARSON, CA B; RUSSELL, TW; TULLY, DC; Washburne, AD; Wenseleers, T; Gimma, A; WAITES, W; WONG, KL M; VAN ZANDVOORT, K; Silverman, JD; CMMID COVID-19 Working Group,; COVID-19 Genomics UK (COG-UK) Consortium,; DIAZ-ORDAZ, K; KEOGH, R; EGGO, RM; FUNK, S; JIT, M; ATKINS, KE; EDMUNDS, WJ;

2021

Science (New York, N.Y.), (2021).372 6538 10.1126/science.abg3055.

Prevalence of SARS-CoV-2 Antibodies From a National Serosurveillance of Kenyan Blood Donors, January-March 2021.

Uyoga, S; ADETIFA, IM O; OTIENDE, M; Yegon, C; AGWEYU, A; Warimwe, GM; SCOTT, JA G;

2021

Journal of the American Medical Association, (2021).326 14 10.1001/jama.2021.15265.

Public health emergency or opportunity to profit? The two faces of the COVID-19 pandemic.

Van Schalkwyk, MC; Maani, N; MCKEE, M;

2021

LANCET DIABETES & ENDOCRINOLOGY, (2021).9 2 10.1016/S2213-8587(21)00001-2.

Correction to: Epidemiological and clinical characteristics of patients with suspected COVID-19 admitted in Metro Manila, Philippines.

Salva, EP; Villarama, JB; Lopez, EB; Sayo, AR; Villanueva, AM G; EDWARDS, T; HAN, SM; Suzuki, S; Seposo, X; Ariyoshi, K; SMITH, C;

2021

Tropical medicine and health, (2021).49 1 10.1186/s41182-021-00373-5.

Unexposed populations and potential COVID-19 burden in European countries as of 21st November 2021.

CHAPMAN, L; BARNARD, R; RUSSELL, T; ABBOTT, S; VAN ZANDVOORT, K; DAVIES, N; KUCHARSKI, A;

2021

medRxiv (2021). 10.1101/2021.11.10.21266166.

"Other risks don't stop": adapting a youth sexual and reproductive health intervention in Zimbabwe during COVID-19.

MACKWORTH-YOUNG, CR S; MAVODZA, C; Nyamwanza, R; Tshuma, M; Nzombe, P; DZIVA CHIKWARI, C; TEMBO, M; Dauya, E; Apollo, T; FERRAND, RA; BERNAYS, S;

2021

Sexual and Reproductive Health Matters, (2021).30 1 10.1080/26410397.2022.2029338.

Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs.

Lopez, J; Mommert, M; Mouton, W; Pizzorno, A; Brengel-Pesce, K; Mezidi, M; Villard, M; Lina, B; Richard, J-C; Fassier, J-B; Cheynet, V; Padey, B; Duliere, V; Julien, T; Paul, S; Bastard, P; Belot, A; Bal, A; Casanova, J-L; Rosa-Calatrava, M; Morfin, F; Walzer, T; Trouillet-Assant, S;

2021

The Journal of experimental medicine, (2021).218 10 10.1084/jem.20211211.

COVID-19 vaccines for the European region: an unprecedented challenge.

Kluge, H; MCKEE, M;

2021

LANCET, (2021).397 10286 10.1016/S0140-6736(21)00709-1.

Willingness to participate in COVID-19 vaccine trials; a survey among a population of healthcare workers in Uganda.

KITONSA, J; Kamacooko, O; BAHEMUKA, UM; Kibengo, F; Kakande, A; WAJJA, A; Basajja, V; Lumala, A; Ssemwanga, E; Asaba, R; Mugisha, J; Pierce, BF; Shattock, R; KALEEBU, P; RUZAGIRA, E;

2021

PloS one, (2021).16 5 10.1371/journal.pone.0251992.

Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine.

World Health Organisation SAGE Working Group on CO,; Wilder-smith, A; Hombach, J; Marti, M; O'Brien, K;

2021

Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine (2021).